These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 19343004)
1. Alpha-fetoprotein expressing metastastic adenocarcinoma of the esophago-gastric junction responding favorably to capecitabine and oxaliplatin. Kripp M; Ströbel P; Dinter D; Lukan N; Hochhaus A; Hofheinz RD Anticancer Drugs; 2009 Jan; 20(1):75-8. PubMed ID: 19343004 [TBL] [Abstract][Full Text] [Related]
2. AFP-producing adenocarcinoma of the esophagogastric junction: report of a case with atypical immunohistochemical findings responding to palliative chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT regime). Häussler U; Bitzer M; Bösmüller H; Clasen S; Götz M; Malek NP; Plentz RR Z Gastroenterol; 2016 Oct; 54(10):1147-1150. PubMed ID: 27723906 [TBL] [Abstract][Full Text] [Related]
3. [Complete remission with FLEP chemotherapy for multiple liver metastasis from alpha-fetoprotein-producing gastric cancer--report of a case]. Takahashi T; Kochi M; Kanamori N; Kaiga T; Funada T; Fujii M; Takayama T Gan To Kagaku Ryoho; 2009 Nov; 36(11):1885-8. PubMed ID: 19920393 [TBL] [Abstract][Full Text] [Related]
4. AFP-producing hepatoid adenocarcinoma in association with Barrett's esophagus with multiple liver metastasis responding to paclitaxel/CDDP: a case report. Chiba N; Yoshioka T; Sakayori M; Mikami Y; Miyazaki S; Akiyama S; Otsuka K; Yamaura G; Shibata H; Kato S; Kato S; Ishioka C Anticancer Res; 2005; 25(4):2965-8. PubMed ID: 16080552 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of cisplatin and capecitabine in combination as first line treatment for unselected patients with advanced gastric cancer. Viteri A; Muñoz A; Rubio I; Barceló R; Martínez-Bueno A; Fernández R; Carrera S; López-Vivanco G Acta Oncol; 2007; 46(3):397-9. PubMed ID: 17450479 [No Abstract] [Full Text] [Related]
6. [A case of AFP-producing esophagogastric junction cancer with liver metastases with a good response to chemotherapy]. Nagai Y; Kato T; Harano M; Satoh D; Choda Y; Tokumoto N; Kanazawa T; Matsukawa H; Ojima Y; Idani H; Shiozaki S; Okajima M; Ninomiya M; Ohno S Gan To Kagaku Ryoho; 2014 Nov; 41(12):2349-51. PubMed ID: 25731519 [TBL] [Abstract][Full Text] [Related]
7. A Case of Alpha-Fetoprotein-Producing Adenocarcinoma of the Esophagogastric Junction in which Long-Term Survival Was Achieved by Means of Individualized Multidisciplinary Therapy. Tanaka K; Fujiya M; Ijiri M; Takahashi K; Ando K; Nomura Y; Ueno N; Kashima S; Goto T; Sasajima J; Ito T; Moriichi K; Mizukami Y; Tanabe H; Okumura T J Gastrointest Cancer; 2019 Sep; 50(3):617-620. PubMed ID: 29457212 [No Abstract] [Full Text] [Related]
8. The Effect of Supplementary Omegaven® on the Clinical Outcome of Patients With Advanced Esophagogastric Adenocarcinoma Receiving Palliative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy: A Phase II clinical trial. Eltweri AM; Thomas AL; Chung WY; Morgan B; Thompson J; Dennison AR; Bowrey DJ Anticancer Res; 2019 Feb; 39(2):853-861. PubMed ID: 30711967 [TBL] [Abstract][Full Text] [Related]
9. [A case of AFP-producing gastric cancer responding to the combination of systemic chemotherapy, transcatheter arterial embolization and hepatic infusion chemotherapy]. Shiochi H; Yamada M; Kishina M; Murawaki Y; Miura M; Azumi T; Yuuki T; Tanaka S; Kono M; Yoshimura T; Yoshida M; Shabana M Gan To Kagaku Ryoho; 2009 May; 36(5):843-6. PubMed ID: 19461191 [TBL] [Abstract][Full Text] [Related]
10. [Hepatoid adenocarcinoma of the stomach. A case report]. Jalle T; Gérard C; Lada PE; Sagan C; Gournay J; Arnaud JP; Paineau J; Hamy A Ann Chir; 2006 Mar; 131(3):213-5. PubMed ID: 16293220 [TBL] [Abstract][Full Text] [Related]
11. Combination therapy with oxaliplatin and 5-fluorouracil in a patient with severe hepatic dysfunction associated with metastatic adenocarcinoma of the large bowel. Grenader T; Goldberg A; Gabizon A Anticancer Drugs; 2009 Oct; 20(9):845-7. PubMed ID: 19633535 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of the esophago-gastric junction adenocarcinoma]. Bîrlă R; Losif C; Gîndea C; Hoară P; Constantinoiu S Chirurgia (Bucur); 2008; 103(2):143-53. PubMed ID: 18457092 [TBL] [Abstract][Full Text] [Related]
13. Cervical metastasis of esophagogastric junction cancer. Cai Z; Shu X; Li J; Yang J Indian J Pathol Microbiol; 2012; 55(4):560-2. PubMed ID: 23455807 [TBL] [Abstract][Full Text] [Related]
14. Validation of the Royal Marsden hospital prognostic index in advanced esophagogastric cancer using individual patient data from the REAL 2 study. Chau I; Ashley S; Cunningham D J Clin Oncol; 2009 Jul; 27(19):e3-4. PubMed ID: 19470917 [No Abstract] [Full Text] [Related]
15. Successful treatment with low-dose capecitabine for disseminated esophageal adenocarcinoma. Carstens H; Albertsson M Acta Oncol; 2007; 46(6):866-8. PubMed ID: 17653915 [No Abstract] [Full Text] [Related]
16. Alpha-fetoprotein producing Barrett's esophageal adenocarcinoma: a case report. Shimakawa T; Ogawa K; Naritaka Y; Wagatsuma Y; Katsube T; Hamaguchi K; Konno S; Aiba M; Kajiwara T Anticancer Res; 1999; 19(5C):4369-73. PubMed ID: 10650778 [TBL] [Abstract][Full Text] [Related]
17. A case of alpha-fetoprotein-producing esophageal adenocarcinoma. Chen YY; Hsu WH; Hu HM; Wu DC; Lin WY Kaohsiung J Med Sci; 2013 Feb; 29(2):106-10. PubMed ID: 23347813 [TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin combined with continuous infusion of 5-fluorouracil as first-line chemotherapy in patients with metastatic or recurrent gastric adenocarcinoma. Lim JY; Cho JY; Oh KJ; Choi SH; Lee SI; Jeung HC Chemotherapy; 2009; 55(4):200-6. PubMed ID: 19451710 [TBL] [Abstract][Full Text] [Related]
19. Colonic rupture in a patient on combination chemotherapy for metastasized carcinoma of the esophagogastric junction. Case report and review of the literature. Colucci G; Thaler W; Dejaco H; Marsoner H; Grones A Onkologie; 2005 Apr; 28(4):204-6. PubMed ID: 15840969 [TBL] [Abstract][Full Text] [Related]
20. Metastatic esophageal adenocarcinoma presenting in the iris. Lee WB; Sy HM; Filip DJ; Grossniklaus HE Am J Ophthalmol; 2007 Sep; 144(3):477-9. PubMed ID: 17765442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]